• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型氨磺酰氧基恶唑烷酮的合成、研究(密度泛函理论、药物代谢和毒性预测)及晶体结构:与严重急性呼吸综合征冠状病毒2的相互作用

Synthesis, study (DFT, ADMET) and crystal structure of novel sulfamoyloxy-oxazolidinones: Interaction with SARS-CoV-2.

作者信息

Bouzina Abdeslem, Berredjem Malika, Bouacida Sofiane, Bachari Khaldoun, Marminon Christelle, Borgne Marc Le, Bouaziz Zouhair, Bouone Yousra Ouafa

机构信息

Department of Chemistry, Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modelling Group, Sciences Faculty, Badji-Mokhtar-Annaba University, Box 12, Annaba 23000, Algeria.

Unité de Recherche de Chimie de L'Environnement et Moléculaire Structurale, Université des Fréres Mentouri, Constantine 25000, Algeria.

出版信息

J Mol Struct. 2022 Jun 5;1257:132579. doi: 10.1016/j.molstruc.2022.132579. Epub 2022 Feb 5.

DOI:10.1016/j.molstruc.2022.132579
PMID:35153333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8817226/
Abstract

A new series of sulfamoyloxyoxazolidinone (SOO) derivatives have been synthesized and characterized by single-crystal X-ray diffraction, NMR, IR, MS and EA. Chemical reactivity and geometrical characteristics of the target compounds were investigated using DFT method. The possible binding mode between SOO and Main protease (Mpro) of SARS-CoV-2 and their reactivity were studied using molecular docking simulation. Single crystal X-ray diffraction showed that SOO crystallizes in a monoclinic system with P 2 1 space group. The binding energy of the SARS-CoV-2/Mpro-SOO complex and the calculated inhibition constant using docking simulation showed that the active SOO molecule has the ability to inhibit SARS-CoV2. We studied the prediction of absorption, distribution, properties of metabolism, excretion and toxicity (ADMET) of the synthesized molecules.

摘要

已合成了一系列新的氨磺酰氧基恶唑烷酮(SOO)衍生物,并通过单晶X射线衍射、核磁共振、红外光谱、质谱和元素分析对其进行了表征。使用密度泛函理论(DFT)方法研究了目标化合物的化学反应性和几何特征。利用分子对接模拟研究了SOO与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)主要蛋白酶(Mpro)之间可能的结合模式及其反应性。单晶X射线衍射表明,SOO以单斜晶系P 2 1空间群结晶。SARS-CoV-2/Mpro-SOO复合物的结合能以及使用对接模拟计算的抑制常数表明,活性SOO分子具有抑制SARS-CoV-2的能力。我们研究了合成分子的吸收、分布、代谢、排泄和毒性(ADMET)预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/cd599de240b2/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/d4d7e2c47126/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/a52ec5487c54/sc1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/c928c6706b6a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/c13d20255220/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/d29e91f8edf0/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/95601d6453f1/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/e347f5626edc/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/3ed323b6b7ef/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/06375560c4c2/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/52d3aa3f8a2c/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/cd599de240b2/gr9_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/d4d7e2c47126/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/a52ec5487c54/sc1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/c928c6706b6a/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/c13d20255220/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/d29e91f8edf0/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/95601d6453f1/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/e347f5626edc/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/3ed323b6b7ef/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/06375560c4c2/gr7_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/52d3aa3f8a2c/gr8_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b06/8817226/cd599de240b2/gr9_lrg.jpg

相似文献

1
Synthesis, study (DFT, ADMET) and crystal structure of novel sulfamoyloxy-oxazolidinones: Interaction with SARS-CoV-2.新型氨磺酰氧基恶唑烷酮的合成、研究(密度泛函理论、药物代谢和毒性预测)及晶体结构:与严重急性呼吸综合征冠状病毒2的相互作用
J Mol Struct. 2022 Jun 5;1257:132579. doi: 10.1016/j.molstruc.2022.132579. Epub 2022 Feb 5.
2
Crystal structure, chemical reactivity, kinetic and thermodynamic studies of new ligand derived from 4-hydroxycoumarin: Interaction with SARS-CoV-2.源自4-羟基香豆素的新型配体的晶体结构、化学反应性、动力学及热力学研究:与严重急性呼吸综合征冠状病毒2的相互作用
J Mol Struct. 2020 Dec 15;1222:128918. doi: 10.1016/j.molstruc.2020.128918. Epub 2020 Jul 16.
3
Sterenin M as a potential inhibitor of SARS-CoV-2 main protease identified from MeFSAT database using molecular docking, molecular dynamics simulation and binding free energy calculation.从 MeFSAT 数据库中使用分子对接、分子动力学模拟和结合自由能计算鉴定出甾醇 N 作为 SARS-CoV-2 主蛋白酶的潜在抑制剂。
Comput Biol Med. 2021 Aug;135:104568. doi: 10.1016/j.compbiomed.2021.104568. Epub 2021 Jun 12.
4
Synthesis, molecular docking, and in silico ADMET studies of 4-benzyl-1-(2,4,6-trimethyl-benzyl)-piperidine: Potential Inhibitor of SARS-CoV2.4-苄基-1-(2,4,6-三甲基金刚烷)-哌啶的合成、分子对接和计算机 ADMET 研究:SARS-CoV2 的潜在抑制剂。
Bioorg Chem. 2021 Jul;112:104967. doi: 10.1016/j.bioorg.2021.104967. Epub 2021 May 5.
5
Synthesis, characterization, computational analyses, in silico ADMET studies, and inhibitory action against SARS-CoV-2 main protease (Mpro) of a Schiff base.席夫碱的合成、表征、计算分析、计算机辅助ADMET研究以及对严重急性呼吸综合征冠状病毒2型主要蛋白酶(Mpro)的抑制作用
Turk J Chem. 2022 Jun 2;46(5):1548-1564. doi: 10.55730/1300-0527.3460. eCollection 2022.
6
Synthesis, crystal structure, Hirshfeld surface analysis, DFT, molecular docking and molecular dynamic simulation studies of (E)-2,6-bis(4-chlorophenyl)-3-methyl-4-(2-(2,4,6-trichlorophenyl)hydrazono)piperidine derivatives.(E)-2,6-双(4-氯苯基)-3-甲基-4-(2-(2,4,6-三氯苯基)肼基)哌啶衍生物的合成、晶体结构、 Hirshfeld表面分析、密度泛函理论、分子对接和分子动力学模拟研究
J Mol Struct. 2022 Oct 15;1266:133483. doi: 10.1016/j.molstruc.2022.133483. Epub 2022 Jun 8.
7
Novel α-aminophosphonate derivates synthesis, theoretical calculation, Molecular docking, and in silico prediction of potential inhibition of SARS-CoV-2.新型α-氨基膦酸酯衍生物的合成、理论计算、分子对接及对严重急性呼吸综合征冠状病毒2潜在抑制作用的计算机模拟预测
J Mol Struct. 2023 Jan 15;1272:134196. doi: 10.1016/j.molstruc.2022.134196. Epub 2022 Sep 28.
8
Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi").通过对牡荆(“Lagundi”)已知化学成分的虚拟筛选发现潜在 SARS-COV-2 主蛋白酶抑制剂“鸡尾酒”。
Med Chem. 2022;18(3):364-381. doi: 10.2174/1573406417666210618132003.
9
Synthesis, spectroscopic characterization of novel phthalimides derivatives bearing a 1,2,3-triazole unit and examination as potential SARS-CoV-2 inhibitors via studies.新型含1,2,3-三唑单元的邻苯二甲酰亚胺衍生物的合成、光谱表征及通过研究作为潜在的SARS-CoV-2抑制剂的考察。
J Mol Struct. 2022 Aug 5;1261:132915. doi: 10.1016/j.molstruc.2022.132915. Epub 2022 Mar 23.
10
Novel pseudonucleosides and sulfamoyl-oxazolidinone --glucosamine derivative as anti-COVID-19: design, synthesis, and study.新型假核苷和磺酰基-噁唑烷酮-葡萄糖胺衍生物作为抗 COVID-19 药物:设计、合成与研究。
J Biomol Struct Dyn. 2023 Dec;41(20):10999-11016. doi: 10.1080/07391102.2023.2203246. Epub 2023 Apr 26.

引用本文的文献

1
Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations.天然产物作为针对非小细胞肺癌的选择性PI3Kα抑制剂的鉴定:多配体药效团建模、分子对接、药物代谢动力学/药物代谢和排泄、密度泛函理论及分子动力学模拟
Mol Divers. 2024 Oct;28(5):2983-3010. doi: 10.1007/s11030-023-10727-2. Epub 2023 Sep 15.

本文引用的文献

1
[Cu(dipicolinoylamide)(NO)(HO)] as anti-COVID-19 and antibacterial drug candidate: Design, synthesis, crystal structure, DFT and molecular docking.[二吡啶甲酰胺铜(I)(硝酰基)(水)]作为抗COVID-19和抗菌药物候选物:设计、合成、晶体结构、密度泛函理论和分子对接
J Mol Struct. 2022 Jan 5;1247:131348. doi: 10.1016/j.molstruc.2021.131348. Epub 2021 Aug 22.
2
A possible potential COVID-19 drug candidate: Diethyl 2-(2-(2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetyl)hydrazono)malonate: Docking of disordered independent molecules of a novel crystal structure, HSA/DFT/XRD and cytotoxicity.一种可能的新型冠状病毒病候选药物:2-(2-(2-(3-甲基-2-氧代喹喔啉-1(2H)-基)乙酰基)肼基)丙二酸二乙酯:新型晶体结构无序独立分子的对接、人血清白蛋白/密度泛函理论/ X射线衍射及细胞毒性
Arab J Chem. 2022 Feb;15(2):103595. doi: 10.1016/j.arabjc.2021.103595. Epub 2021 Nov 28.
3
Repurposing an Antiviral Drug against SARS-CoV-2 Main Protease.抗 SARS-CoV-2 主蛋白酶的抗病毒药物再利用。
Angew Chem Int Ed Engl. 2021 Oct 25;60(44):23492-23494. doi: 10.1002/anie.202107481. Epub 2021 Sep 21.
4
Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.羟乙胺类似物的抗病毒评估:针对 SARS-CoV-2 主蛋白酶(3CLpro)的抑制剂,一种虚拟筛选和模拟方法。
Bioorg Med Chem. 2021 Oct 1;47:116393. doi: 10.1016/j.bmc.2021.116393. Epub 2021 Sep 4.
5
SARS-CoV-2 M: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors.SARS-CoV-2 M:肽模拟物和小分子抑制剂的潜在靶标。
Biomolecules. 2021 Apr 19;11(4):607. doi: 10.3390/biom11040607.
6
structure-based discovery of a SARS-CoV-2 main protease inhibitor.基于结构的新型冠状病毒主要蛋白酶抑制剂的发现
Int J Biol Sci. 2021 Apr 10;17(6):1555-1564. doi: 10.7150/ijbs.59191. eCollection 2021.
7
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease.SARS-CoV-2 主蛋白酶的晶体学和亲电片段筛选。
Nat Commun. 2020 Oct 7;11(1):5047. doi: 10.1038/s41467-020-18709-w.
8
Photochemically Mediated Nickel-Catalyzed Synthesis of -(Hetero)aryl Sulfamides.光化学介导的镍催化 -(杂)芳基磺酰胺合成。
J Org Chem. 2020 May 15;85(10):6380-6391. doi: 10.1021/acs.joc.0c00139. Epub 2020 May 4.
9
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.新型冠状病毒病(COVID-19)在早期暴发期间的流行病学、病因、临床表现和诊断、预防和控制:范围综述。
Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x.
10
[Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].[RAS 抑制剂可能是治疗 COVID-19 肺炎的良好选择]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):219-222. doi: 10.3760/cma.j.issn.1001-0939.2020.03.016.